đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this study is to find out whether N10 chemotherapy is a safe...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2024-07-22
Trial ID
NCT06528496
Background: X-linked severe combined immunodeficiency (XSCID) is a rare in...
Status
Enrolling By Invitation
Location
National Institutes of Health Clinical Center
Start Date
2025-05-09
Trial ID
NCT06851767
Treatments Being Tested
compare the efficacy and safety of TCbHP and EC-THP regimen in HER2-positiv...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2023-06-07
Trial ID
NCT05883852
Treatments Being Tested
This study adds irinotecan, temozolomide and bevacizumab to the chemotherap...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2010-08
Trial ID
NCT01189643
To explore the efficacy and safety of TQB2825 injection combined immunochem...
Status
Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2025-04-23
Trial ID
NCT06829771
Treatments Being Tested
The purpose of this study is to learn about the safety and effects of the s...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2024-12-10
Trial ID
NCT06704724
The aim of this study is to find the appropriate dose of eltrombopag in thr...
Status
Terminated
Location
Medizinische UniversitÀt Wien, Innere Medizin I, Abt. HÀmatologie und HÀmastaseologie
Start Date
2011-10
Trial ID
NCT01397149
Treatments Being Tested
This clinical trial evaluates adding ferumoxytol and pharamcologic ascorbat...
Status
Active Not Recruiting
Location
Department of Radiation Oncology at University of Iowa
Start Date
2023-02-28
Trial ID
NCT04900792
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Yale Comprehensive Cancer Center
Start Date
1994-02
Trial ID
NCT00002680
The aim of this study is to assess the safety, side effects and effectivene...
Status
Recruiting
Location
David Geffen School of Medicine at UCLA
Start Date
2022-09-30
Trial ID
NCT05443126
Treatments Being Tested